Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use Of Autologous Stem Cell Use In Neurological Non-neoplastic Disorders And Disease

NCT03297177 is registered in ClinicalTrials.gov with Regeneris Medical as lead sponsor.

NCT NCT03297177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03297177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use Of Autologous Stem Cell Use In Neurological Non-neoplastic Disorders And Disease
Lead sponsor
Regeneris Medical
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2020
Completion date
January 1, 2023
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

altered behavior in alzheimer disease, corticobasal degeneration, dementia, demyelinating autoimmune diseases, cns, demyelinating sensorimotor neuropathy, parkinson